Medications

Cancer drugs promote stem cell properties of colorectal cancer

Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the ...

Oncology & Cancer

Mystery molecule is a key to inhibiting colon cancer

Immunologists at St. Jude Children's Research Hospital have discovered that a protein called NLRC3 plays a central role in inhibiting colon cells from becoming cancerous. The study, led by Thirumala-Devi Kanneganti, Ph.D., ...

Oncology & Cancer

Technologies give high-resolution 'snapshot' of cancer tissues

(Medical Xpress) -- Stanford researchers have melded tools and technologies from engineering, computer science and stem cell biology to analyze hundreds of individual cancer cells and draw the most accurate portrait yet of ...

page 8 from 38